EMG
ONC icon

Ellington Management Group’s BeOne Medicines Ltd ONC Stock Holding History

Ellington Management Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,700
Closed -$332K – 461
2020
Q1 		$332K Buy
+2,700
New +$422K 0.08% 308
2019
Q3 		– Sell
-3,200
Closed -$397K – 835
2019
Q2 		$397K Buy
+3,200
New +$406K 0.07% 288
2018
Q4 		– Sell
-4,500
Closed -$775K – 626
2018
Q3 		$775K Buy
+4,500
New +$757K 0.21% 148
2018
Q2 		– Sell
-4,600
Closed -$773K – 907
2018
Q1 		$773K Sell
4,600
-2,000
-30% -$271K 0.06% 276
2017
Q4 		$645K Buy
+6,600
New +$604K 0.11% 157

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Ellington Management Group's ONC Position: Q2 2020 in Review

Ellington Management Group sold out of BeOne Medicines Ltd (ONC) in Q2 2020, closing a stake of 2,700 shares — an estimated $332K sold.

Ellington Management Group first reported a position in ONC in Q4 2017 and held it in 5 quarters. The position peaked at $775K in Q3 2018. 220 funds tracked by Wall St. Rank hold ONC as of Q2 2020.

  • Ellington Management Group reported no remaining BeOne Medicines Ltd position as of Q2 2020 after selling out during the quarter.
  • Ellington Management Group sold 2,700 BeOne Medicines Ltd shares in Q2 2020, an estimated $332K.
  • Ellington Management Group first reported a position in BeOne Medicines Ltd in Q4 2017 and held it in 5 quarters.
  • Ellington Management Group's BeOne Medicines Ltd position peaked at $775K in Q3 2018.
  • 220 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2020.

Based on Ellington Management Group's 13F filing for Q2 2020, filed 17 Aug 2020.